This systematic review of the literature regarding treatment of ROP revealed that higher quality studies concluded that LPC leads to greater rates of myopia than intravitreal anti-VEGF treatment, while the rate of adverse events and of unfavorable neurodevelopmental outcomes is similar. Here, VEGFA is linked to myopia.